Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Thyroid Diseases 1Neoplasm Metastasis 1

Interventions

Saline Solution 5Radiofrequency Ablation 5Thyroxine 4Thyroidectomy 4Surgical Procedures, Operative 4Dexmedetomidine 3Decision Support Techniques 3Cryosurgery 3Control Groups 3Biopsy, Fine-Needle 3Watchful Waiting 2Therapeutics 2Surveys and Questionnaires 2Sodium 2Lidocaine 2Iodine-131 2Exercise 2Calcium Carbonate 2Bupivacaine 2Blood Specimen Collection 2Biopsy, Needle 2Biopsy 2dabrafenib 1Whey Proteins 1Water 1Vitamin D 1Triiodothyronine 1Transcutaneous Electric Nerve Stimulation 1Tea 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Thyroid Neoplasms × AZD 6244 × Clear all
NCT00970359 2017-04-12

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Memorial Sloan Kettering Cancer Center

Phase NA Completed
24 enrolled 8 charts
Head & Neck

Neoplasm Metastasis, Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡